Could a home ultrasound device transform gestational diabetes care?

NCT ID NCT07158970

Recruiting now Symptom relief Sponsor: Wolfson Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study will test whether giving women with gestational diabetes a home ultrasound device, guided remotely by a doctor, improves their satisfaction and health outcomes compared to standard care. About 90 participants will use the device for fetal checks from home. The goal is to see if this approach makes care more convenient and effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Pulsenmore home ultrasound device
What this could lead to: If successful, this could make pregnancy monitoring more convenient and satisfying for women with gestational diabetes, potentially reducing clinic visits and healthcare costs.
What could go wrong: This is a small, early-stage study (90 participants) that hasn't started yet. The device may not improve outcomes or satisfaction significantly, and results may not apply to non-Hebrew speakers or those with multiple pregnancies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gestational diabetes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GESTATIONAL DIABETES MELLITUS

Contacts and locations

Locations

Edith Wolfson Medical Center
RECRUITING

H̱olon, Central District, 5834468, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.